HomeVYNE • NASDAQ
add
Vyne Therapeutics Inc
Previous close
$1.00
Day range
$0.96 - $1.02
Year range
$0.91 - $4.30
Market cap
16.63M USD
Avg Volume
288.08K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 202.00K | 106.12% |
Operating expense | 9.40M | 25.69% |
Net income | -8.61M | -37.80% |
Net profit margin | -4.26K | 33.15% |
Earnings per share | — | — |
EBITDA | -9.19M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 50.27M | -41.51% |
Total assets | 56.42M | -38.45% |
Total liabilities | 12.29M | 47.98% |
Total equity | 44.13M | — |
Shares outstanding | 16.66M | — |
Price to book | 0.36 | — |
Return on assets | -37.29% | — |
Return on capital | -47.71% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -8.61M | -37.80% |
Cash from operations | -11.46M | -43.60% |
Cash from investing | 19.83M | 655.65% |
Cash from financing | -87.00K | -1,640.00% |
Net change in cash | 8.28M | 171.68% |
Free cash flow | -9.19M | -58.45% |
About
Founded
2003
Headquarters
Website
Employees
13
